Plasma Protease C1-inhibitor Market Growing at 9.6% CAGR To Reach US$ 7.96 Billion From 2024 to 2032
The growing cases of Hereditary Angioedema (HAE) is a prominent factor driving the plasma protease C1-inhibitor market. NEW YORK CITY, NY, UNITED STATES, October 21, 2024 /EINPresswire.com/ -- The plasma protease C1-inhibitor market forecast for 2032 is …